Results 61 to 70 of about 32,721 (222)

Systemic manifestations in the course of meningococcal disease [PDF]

Vojnosanitetski Pregled, 2009
Background/Aim. Meningococcal disease most often manifests itself as meningitis or sepsis. During the course of these diseases, other clinical events sometimes develop such as pneumonia, pericarditis, arthritis, and they are referred to as extrameningeal
Dulović Olga, Stevanović Goran, Milošević Branko, Gvozdenović Eleonora, Dokić Ljubiša, Popović Nataša, Nikolić Svetlana, Pavlović Milorad   +7 more
doaj   +1 more source

Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles

European Journal of Immunology, Volume 56, Issue 6, June 2026.
Complement therapeutics have expanded considerably, but systemic inhibitors remain limited by infection risks, breakthrough events, and loss of physiological functions. Emerging targeted approaches aim for organ‐, tissue‐, or cell‐specific modulation of complement activity, potentially offering greater precision while reducing treatment burden and ...
Marco Mannes, Wioleta M. Zelek, Leendert A. Trouw   +2 more
wiley   +1 more source

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect

npj Vaccines, 2021
Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical manifestations, but the bacteria share up to 80–90% genome sequence identity.
Yara Ruiz García, Woo-Yun Sohn, Kate L. Seib, Muhamed-Kheir Taha, Julio A. Vázquez, Ana Paula S. de Lemos, Kumaran Vadivelu, Mariagrazia Pizza, Rino Rappuoli, Rafik Bekkat-Berkani   +9 more
doaj   +1 more source

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

, 2010
In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance.
Perrocheau, Anne, Celentano, Lucia Pastore, Stuart, James, de Greeffk, Sabine C, Kissling E, Lévy-Bruhl, Daniel, ECDC Country Experts for Pneumococcal Disease, Celentano LP, de Greeff, Sabine C, Tarragó, David, Stefanoff P, Amato-Gauci A, Kriz, Paula, Heuberger, Sigrid, Amato-Gauci, Andrew, Bruhl DL, Tarragó D, de Greef SC, Kriz P, Hanquet G, Kissling, Esther, ECDC country experts for pneumococcal disease, incl., Vergison A, Hanquet, Germaine, Stefanoff, Pawel, Heuberger S, Vergison, Anne, Bruhl, Daniel Levy, Perrocheau A, de Greeff, Sabine C., Stuart J, Mühlemann, Kathrin   +31 more
core   +1 more source

Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review

Infectious Diseases and Therapy, 2019
Neisseria meningitidis is a major cause of meningitis and septicemia with cases, outbreaks, and epidemics reported globally in industrialized and non-industrialized countries. N. meningitidis is categorized into 12 serogroups; however, only 5 serogroups (
Jessica Presa, Jamie Findlow, Jelena Vojicic, Scott Williams, Lidia Serra   +4 more
doaj   +1 more source

Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.
ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode, Mitchel C. Rothholz, Stephan L. Foster, Erica R. Brody, John D. Gräbenstein   +4 more
wiley   +1 more source

Meningococcal conjugate vaccines: optimizing global impact

Infection and Drug Resistance, 2011
Andrew Terranella1,2, Amanda Cohn2, Thomas Clark2 1Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office, 2Meningitis and Vaccine Preventable Diseases Branch, National Center for ...
Terranella A, Cohn A, Clark T
doaj  

Meningococcal disease and climate

Global Health Action, 2009
Invasive meningococcal disease (IMD) is an epidemic infectious disease highly influenced by climatic factors. Climate plays an important role in both the spatial distribution of the disease and in the seasonality of IMD as seen all over the world. It is mentioned as one of the infectious diseases likely to be affected by climate change in the Fourth ...
openaire   +2 more sources

Early diagnosis model for meningitis supports public health decision making.

, 2011
OBJECTIVE: To develop a predictive model for rapid differential diagnosis of meningitis and meningococcal septicaemia to support public health decisions on chemoprophylaxis for contacts.
Ejidokun, Oluwatoyin O, Meltzer, Margie, Neville Q. Verlander, Fraser, Graham, Meltzer, M, Oluwatoyin O. Ejidokun, Rehman, Yasmin, Verlander, Neville Q, Ninis, Nelly, Margie Meltzer, Nelly Ninis, Muir, Peter, Fraser, G, Verlander, NQ, Rehman, Y, Close, RM, James M. Stuart, Graham Fraser, Peter Muir, Muir, P, Stuart, James M, Stuart, JM, Rebecca M. Close, Yasmin Rehman, Close, Rebecca M, Ejidokun, OO   +25 more
core   +1 more source

Can near real-time monitoring of emergency department diagnoses facilitate early response to sporadic meningococcal infection? - prospective and retrospective evaluations

BMC Infectious Diseases, 2010
Background Meningococcal infection causes severe, rapidly progressing illness and reporting of cases is mandatory in New South Wales (NSW), Australia.
Zheng Wei, Muscatello David J, O'Toole Libby, Churches Tim   +3 more
doaj   +1 more source